Jean-Sébastien Hulot to Treatment Outcome
This is a "connection" page, showing publications Jean-Sébastien Hulot has written about Treatment Outcome.
Connection Strength
0.040
-
Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial. Eur J Heart Fail. 2017 11; 19(11):1534-1541.
Score: 0.025
-
Long-Term Evolution of Premature Coronary Artery Disease. J Am Coll Cardiol. 2019 10 15; 74(15):1868-1878.
Score: 0.008
-
Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support. EuroIntervention. 2018 04 06; 13(18):e2160-e2168.
Score: 0.007